From the editor: an interview with Dr. Scott Grundy

J Clin Lipidol. 2014 Jan-Feb;8(1):1-8. doi: 10.1016/j.jacl.2013.12.004. Epub 2013 Dec 14.

Abstract

During the American Heart Association's Scientific Sessions in November 2014, this Editor had the opportunity to interview Dr. Scott Grundy regarding the new recommendations for guideline development that was issued by the International Atherosclerosis Society. (The full document is published in this issue of the journal). In developing this report, Dr. Grundy chaired a panel of international experts who spent 1 year in consideration of new evidence and regional concerns regarding the clinical management of lipoprotein disorders and vascular disease prevention. His experience in developing the Adult Treatment Panel Reports from the National Cholesterol Education Program in the United States and his extensive research in lipoprotein physiology and related disorders makes him unique in offering the expertise for worldwide leadership in this effort.

Keywords: Dyslipidemia; Guidelines; HDL; LDL; Lipoproteins.

Publication types

  • Interview

MeSH terms

  • Advisory Committees
  • Animals
  • Anticholesteremic Agents / therapeutic use
  • Atherosclerosis / blood
  • Atherosclerosis / drug therapy
  • Atherosclerosis / genetics
  • Atherosclerosis / pathology
  • Clinical Trials as Topic
  • Dyslipidemias / blood
  • Dyslipidemias / drug therapy*
  • Dyslipidemias / genetics
  • Dyslipidemias / pathology*
  • Humans
  • Practice Guidelines as Topic
  • Triglycerides / blood

Substances

  • Anticholesteremic Agents
  • Triglycerides